Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
transcatheter arterial chemoembolization (2432) 2432
humans (1848) 1848
hepatocellular carcinoma (1731) 1731
index medicus (1357) 1357
male (1291) 1291
liver neoplasms - therapy (1210) 1210
female (1204) 1204
middle aged (1132) 1132
carcinoma, hepatocellular - therapy (1115) 1115
aged (1005) 1005
treatment outcome (807) 807
transarterial chemoembolization (785) 785
oncology (783) 783
radiology, nuclear medicine & medical imaging (755) 755
adult (683) 683
liver neoplasms - pathology (679) 679
gastroenterology & hepatology (672) 672
liver cancer (650) 650
cancer (640) 640
hepatoma (618) 618
carcinoma, hepatocellular - pathology (612) 612
embolization (579) 579
survival (544) 544
chemoembolization, therapeutic - methods (541) 541
retrospective studies (500) 500
liver (497) 497
radiofrequency ablation (486) 486
care and treatment (480) 480
liver neoplasms - mortality (472) 472
chemoembolization, therapeutic (468) 468
carcinoma, hepatocellular - mortality (449) 449
prognosis (439) 439
surgery (420) 420
aged, 80 and over (418) 418
transcatheter arterial embolization (413) 413
therapy (384) 384
survival rate (372) 372
medicine & public health (353) 353
tumors (349) 349
chemotherapy (344) 344
chemoembolization (338) 338
hepatocellular-carcinoma (334) 334
liver neoplasms - diagnostic imaging (305) 305
combined modality therapy (297) 297
carcinoma, hepatocellular - diagnostic imaging (273) 273
management (271) 271
chemoembolization, therapeutic - adverse effects (270) 270
tomography, x-ray computed (269) 269
randomized controlled trial (261) 261
percutaneous ethanol injection (260) 260
radiotherapy (260) 260
liver neoplasms - drug therapy (258) 258
liver neoplasms - surgery (258) 258
antineoplastic agents - administration & dosage (246) 246
cirrhosis (243) 243
hepatectomy (235) 235
carcinoma, hepatocellular - surgery (233) 233
survival analysis (230) 230
carcinoma, hepatocellular - drug therapy (226) 226
risk factors (224) 224
neoplasm staging (214) 214
resection (209) 209
patients (205) 205
hepatic resection (203) 203
sorafenib (201) 201
efficacy (196) 196
follow-up studies (196) 196
analysis (194) 194
recurrence (194) 194
tace (190) 190
ablation (186) 186
unresectable hepatocellular-carcinoma (185) 185
imaging / radiology (183) 183
time factors (182) 182
magnetic resonance imaging (179) 179
animals (176) 176
radiology (169) 169
liver-transplantation (164) 164
randomized controlled-trial (164) 164
iodized oil (162) 162
liver neoplasms - diagnosis (158) 158
liver neoplasms - radiotherapy (158) 158
abridged index medicus (155) 155
ultrasound (154) 154
health aspects (151) 151
carcinoma, hepatocellular - radiotherapy (149) 149
digestive system diseases (149) 149
metastasis (149) 149
microspheres (149) 149
antineoplastic agents - therapeutic use (145) 145
cisplatin (145) 145
contrast media (145) 145
angiography (144) 144
doxorubicin - administration & dosage (141) 141
embolization, therapeutic - methods (139) 139
nuclear medicine (138) 138
prognostic-factors (138) 138
prospective studies (138) 138
carcinoma, hepatocellular - diagnosis (137) 137
hcc (136) 136
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2989) 2989
Korean (46) 46
Japanese (41) 41
German (38) 38
French (25) 25
Spanish (4) 4
Chinese (3) 3
Italian (3) 3
Polish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
by Yin, L and Li, H and Li, AJ and Lau, WY and Pan, ZY and Lai, ECH and Wu, MC and Zhou, WP
JOURNAL OF HEPATOLOGY, ISSN 0168-8278, 07/2014, Volume 61, Issue 1, pp. 82 - 88
Background & Aims: The aim of this randomized comparative trial (RCT) is to compare partial hepatectomy (PH) with transcatheter arterial chemoembolization... 
Multiple hepatocellular carcinoma | RCT | CYTOREDUCTIVE SURGERY | PROGNOSTIC-FACTORS | ELUTING BEADS | Partial hepatectomy | HEPATIC RESECTION | MULTIDISCIPLINARY TREATMENT | PREDICTION | MICROVASCULAR INVASION | TRANSARTERIAL CHEMOEMBOLIZATION | REDUCTION SURGERY | Overall survival | GASTROENTEROLOGY & HEPATOLOGY | Transcatheter arterial chemoembolization | EPIDEMIOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
by Yin, Lei and Li, Hui and Li, Ai-Jun and Lau, Wan Yee and Pan, Ze-ya and Lai, Eric C.H and Wu, Meng-chao and Zhou, Wei-Ping
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 1, pp. 82 - 88
Background & Aims The aim of this randomized comparative trial (RCT) is to compare partial hepatectomy (PH) with transcatheter arterial chemoembolization... 
Gastroenterology and Hepatology | Multiple hepatocellular carcinoma | RCT | Partial hepatectomy | Overall survival | Transcatheter arterial chemoembolization | Neoplasms, Multiple Primary - mortality | Neoplasms, Multiple Primary - surgery | Carcinoma, Hepatocellular - mortality | Prognosis | Hepatectomy - adverse effects | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Neoplasms, Multiple Primary - therapy | Adult | Chemoembolization, Therapeutic - adverse effects | Female | Carcinoma, Hepatocellular - therapy | Practice Guidelines as Topic | Hepatoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: Comparison with surgical resection
by Kagawa, Tatehiro and Koizumi, Jun and Kojima, Sei-Ichiro and Nagata, Naruhiko and Numata, Makoto and Watanabe, Norihito and Watanabe, Tetsu and Mine, Tetsuya and Dowaki, Shoichi and Tobita, Kosuke and Imaizumi, Toshihide and Shiraishi, Koichi and Takashimizu, Shinji and Ohtani, Yasuo and Iwata, Yoshiro and Tokai RFA Study Grp and Tokai RFA Study Group
Cancer, ISSN 0008-543X, 08/2010, Volume 116, Issue 15, pp. 3638 - 3644
BACKGROUND: Radiofrequency ablation (RFA) is becoming a well-known local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization... 
Radiofrequency ablation | Hepatocellular carcinoma | Transcatheter arterial chemoembolization | Liver | transcatheter arterial chemoembolization | liver | HEPATECTOMY | RANDOMIZED CONTROLLED-TRIAL | TRANSPLANTATION | THERMAL ABLATION | ONCOLOGY | PERCUTANEOUS ETHANOL INJECTION | CIRRHOSIS | LIVER-TUMORS | radiofrequency ablation | MICROWAVE COAGULATION THERAPY | CLIP SCORE | HEPATITIS-C | hepatocellular carcinoma | Recurrence | Carcinoma, Hepatocellular - mortality | Humans | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Combined Modality Therapy | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Hepatectomy | Chemoembolization, Therapeutic - adverse effects | Female | Aged | Carcinoma, Hepatocellular - therapy | Catheter Ablation - adverse effects | Care and treatment | Therapeutic embolization | Hepatoma | Research | Patient outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization
by Morimoto, Manabu and Numata, Kazushi and Kondou, Masaaki and Nozaki, Akito and Morita, Satoshi and Tanaka, Katsuaki
Cancer, ISSN 0008-543X, 12/2010, Volume 116, Issue 23, pp. 5452 - 5460
To improve the efficacy of radiofrequency ablation (RFA) for the treatment of intermediate-sized hepatocellular carcinomas (HCCs), the authors compared RFA... 
combination therapy | transcatheter arterial chemoembolization | radiofrequency ablation | local tumor progression | hepatocellular carcinoma | survival | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Treatment Outcome | Liver Neoplasms - therapy | Combined Modality Therapy - adverse effects | Liver Neoplasms - mortality | Disease Progression | Catheter Ablation - methods | Chemoembolization, Therapeutic - methods | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy
by Brown, Daniel B., MD and Nikolic, Boris, MD, MBA and Covey, Anne M., MD and Nutting, Charles W., DO and Saad, Wael E.A., MD and Salem, Riad, MD, MBA and Sofocleous, Constantinos T., MD, PhD and Sze, Daniel Y., MD, PhD and Society of Interventional Radiology Standards of Practice Committee
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2012, Volume 23, Issue 3, pp. 287 - 294
Radiology | PHASE-II TRIAL | TRANSCATHETER OILY CHEMOEMBOLIZATION | INFERIOR PHRENIC ARTERY | LONG-TERM SURVIVAL | DRUG-ELUTING BEAD | UNRESECTABLE HEPATOCELLULAR-CARCINOMA | TRANSARTERIAL CHEMOEMBOLIZATION | PERIPHERAL VASCULAR DISEASE | COLORECTAL LIVER METASTASES | RANDOMIZED CONTROLLED-TRIAL | RADIOFREQUENCY THERMAL ABLATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Risk Assessment | Humans | Hepatic Artery | Liver Neoplasms - drug therapy | Quality Improvement - standards | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Embolization, Therapeutic - adverse effects | Patient Selection | Evidence-Based Medicine - standards | Chemoembolization, Therapeutic - standards | Liver Neoplasms - blood supply | Antineoplastic Agents - adverse effects | Embolization, Therapeutic - standards | Chemoembolization, Therapeutic - adverse effects | Infusions, Intra-Arterial | Injections, Intra-Arterial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text High-intensity focused ultrasound combined with transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma A case report
by Liu, YE and Zong, J and Ren, XC and Lin, Q
MEDICINE, ISSN 0025-7974, 08/2019, Volume 98, Issue 31, p. e16660
Introduction: Primary hepatocellular carcinoma (HCC) is one of the most common malignancies, only 10% to 20% of HCC patients are surgically resectable as most... 
SURVIVAL | MEDICINE, GENERAL & INTERNAL | transcatheter arterial chemoembolization | three-dimensional conformal radiotherapy | primary hepatocellular carcinoma | portal vein tumor thrombus | TRANSARTERIAL CHEMOEMBOLIZATION | comprehensive strategy | high-intensity focused ultrasound | RADIATION-THERAPY | Case studies | Therapeutic chemoembolization | Care and treatment | Usage | Ultrasonics in medicine | Patient outcomes | Combined modality therapy | Venous thrombosis | Hepatoma | Radiotherapy | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
by Wei, Yanyan and Dai, Feng and Zhao, Tianhui and Tao, Chen and Wang, Lili and Ye, Wei and Zhao, Wei
Cancer Management and Research, ISSN 1179-1322, 2018, Volume 10, pp. 5273 - 5282
Background: The prognosis of massive hepatocellular carcinomas (MHCCs; >= 10 cm) remains worse. Purpose: The aim of this study was to evaluate the clinical... 
TACE | PMCT | Percutaneous microwave coagulation therapy | Transcatheter arterial chemoembolization | Massive hepatocellular carcinoma | transcatheter arterial chemoembolization | PROGNOSTIC-FACTORS | ALPHA-FETOPROTEIN LEVELS | PHASE-II | HCC | massive hepatocellular carcinoma | LIVER-CANCER | THERMAL ABLATION | percutaneous microwave coagulation therapy | ONCOLOGY | TRANSARTERIAL CHEMOEMBOLIZATION | TUMOR SIZE | RADIOFREQUENCY ABLATION | Usage | Prognosis | Hepatoma | Arterial catheterization | Hypertension | Nuclear magnetic resonance--NMR | Medical imaging | Transplants & implants | Laboratories | Mortality | Family medical history | Metastasis | Medical diagnosis | Patients | Cancer therapies | Liver cancer | Hepatitis | Medical prognosis | Diabetes | Veins & arteries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus
by Peng, Zhen‐Wei and Guo, Rong‐Ping and Zhang, Yao‐Jun and Lin, Xiao‐Jun and Chen, Min‐Shan and Lau, Wan Y
Cancer, ISSN 0008-543X, 10/2012, Volume 118, Issue 19, pp. 4725 - 4736
BACKGROUND: The long‐term survival outcomes of hepatic resection (HR) compared with transcatheter arterial chemoembolization (TACE) for resectable... 
portal vein tumor thrombus | overall survival | hepatic resection | transcatheter arterial chemoembolization | hepatocellular carcinoma | disease‐free survival | disease-free survival | SURVIVAL | LIVER-TRANSPLANTATION | MANAGEMENT | EMBOLIZATION | HEPATECTOMY | PROGNOSIS | CLASSIFICATION | SURGICAL-TREATMENT | RANDOMIZED CONTROLLED TRIAL | ONCOLOGY | TRANSARTERIAL CHEMOEMBOLIZATION | Chemoembolization, Therapeutic | Humans | Middle Aged | Liver Neoplasms - complications | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Male | Treatment Outcome | Liver Neoplasms - therapy | Portal Vein | Case-Control Studies | Hepatectomy | Analysis of Variance | Carcinoma, Hepatocellular - complications | Thrombosis - etiology | Neoplastic Cells, Circulating | Survival Analysis | Adult | Female | Aged | Carcinoma, Hepatocellular - therapy | Retrospective Studies | Thrombosis - therapy | Care and treatment | Hepatoma | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
by Jia-Zhou Ye Jun-Ze Chen Zi-Hui Li Tao Bai Jie Chen Shao-Liang Zhu Le-Qun Li Fei-Xiang Wu
世界胃肠病学杂志：英文版, ISSN 1007-9327, 2017, Volume 23, Issue 41, pp. 7415 - 7424
AIM To investigate the efficacy and safety of postoperative adjuvant transcatheter arterial chemoembolization(PA-TACE) in preventing tumor recurrence and... 
Hepatocellular carcinoma | Recurrence-free survival | Microvascular invasion | Overall survival | Postoperative adjuvant transcatheter arterial chemoembolization | PREDICTOR | HEPATECTOMY | VASCULAR INVASION | SORAFENIB | CANCER | CLINICAL-PRACTICE GUIDELINES | LIVER RESECTION | EARLY RECURRENCE | ABLATION | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | Retrospective Study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: Clinical efficacy and factors influencing outcomes
by Kim, Jin Hyoung and Yoon, Hyun-Ki and Sung, Kyu-Bo and Ko, Gi-Young and Gwon, Dong Il and Shin, Ji Hoon and Song, Ho-Young
Cancer, ISSN 0008-543X, 10/2008, Volume 113, Issue 7, pp. 1614 - 1622
BACKGROUND. The role of transcatheter arterial chemoembolization (TACE) or transcatheter arterial chemoinfusion (TACI) for unresectable intrahepatic... 
Transcatheter arterial chemoembolization | Liver | Intrahepatic cholangiocarcinoma | SURVIVAL | transcatheter arterial chemoembolization | liver | EMBOLIZATION | PERIPHERAL CHOLANGIOCARCINOMA | TUMORS | intrahepatic cholangiocarcinoma | HEPATOCELLULAR-CARCINOMA | CISPLATIN | ONCOLOGY | TRANSARTERIAL CHEMOEMBOLIZATION | MALIGNANCIES | EXPERIENCE | Infusions, Intra-Arterial - methods | Cholangiocarcinoma - therapy | Humans | Middle Aged | Cholangiocarcinoma - mortality | Hepatic Artery | Male | Treatment Outcome | Chemoembolization, Therapeutic - methods | Bile Duct Neoplasms - therapy | Bile Duct Neoplasms - mortality | Survival Analysis | Aged, 80 and over | Adult | Bile Ducts, Intrahepatic | Female | Aged | Retrospective Studies | Chemotherapy | Therapeutic embolization | Research | Patient outcomes | Methods | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Retiform Purpura after Transcatheter Arterial Chemoembolization: A Case Report
by Hansen, Trevor and Olsen, Keith and White, Kevin and Keller, Jesse
American Journal of Dermatopathology, ISSN 0193-1091, 02/2018, Volume 40, Issue 2, pp. e25 - e27
Cutaneous complications secondary to transcatheter arterial chemoembolization (TACE) are exceptionally rare and may occur because of nontarget embolization of... 
retiform purpura | transcatheter arterial chemoembolization | cutaneous complication | SUPRAUMBILICAL SKIN RASH | HEPATOCELLULAR-CARCINOMA | EMBOLIZATION | CUTANEOUS COMPLICATIONS | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | DERMATOLOGY | Purpura (Pathology) | Case studies | Causes of | Complications and side effects | Therapeutic embolization | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review
by Idée, Jean-Marc and Guiu, Boris
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2013, Volume 88, Issue 3, pp. 530 - 549
Abstract Hepatocellular carcinoma (HCC) remains a major public health problem. Transarterial chemoembolization (TACE) is recognized as the standard of care for... 
Hematology, Oncology and Palliative Medicine | Cytotoxic drugs | Interventional radiology | Hepatocellular carcinoma | Lipiodol | Drug delivery | Transcatheter arterial chemoembolization | Theranostics | INTRAARTERIAL INJECTION | IODIZED OIL | ELUTING BEADS | OILY CONTRAST-MEDIUM | LIVER-CANCER | RANDOMIZED CONTROLLED TRIAL | CHEMOTHERAPEUTIC-AGENTS | ONCOLOGY | HEPATIC-ARTERY | TRANSARTERIAL CHEMOEMBOLIZATION | HEMATOLOGY | ENDOTHELIAL GROWTH-FACTOR | Ethiodized Oil - pharmacokinetics | Humans | Treatment Outcome | Combined Modality Therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Ethiodized Oil - adverse effects | Drug Delivery Systems | Chemoembolization, Therapeutic - methods | Ethiodized Oil - administration & dosage | Animals | Chemoembolization, Therapeutic - adverse effects | Carcinoma, Hepatocellular - therapy | Drugs | Usage | Drug delivery systems | Esters | Hepatoma | Fatty acids | Vehicles
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization A retrospective analysis of 509 cases
by Shen, HJ and Zheng, SS and Chen, RX and Jin, XJ and Xu, X and Jing, CY and Lin, JJ and Zhang, J and Zhang, MX and Zhang, L and Xie, XY and Guo, K and Ren, ZZ and Lin, SS and Zhang, BH
MEDICINE, ISSN 0025-7974, 07/2017, Volume 96, Issue 28, p. e7438
Although procalcitonin (PCT) is a valid marker for early diagnosis of bacterial infections, its accuracy in hepatocellular carcinoma (HCC) patients is unknown.... 
C-REACTIVE PROTEIN | SURVIVAL | MORTALITY | DIAGNOSIS | SPONTANEOUS BACTERIAL PERITONITIS | GAMMA-GLUTAMYL-TRANSFERASE | procalcitonin | PREDICTION | transcatheter arterial embolization chemoembolization | MEDICINE, GENERAL & INTERNAL | prognostic value | unresectable hepatocellular carcinoma | SYSTEMIC INFLAMMATORY RESPONSE | CIRRHOTIC-PATIENTS | INFECTION | Multivariate Analysis | Carcinoma, Hepatocellular - mortality | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Liver Neoplasms - blood | Young Adult | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Carcinoma, Hepatocellular - blood | Calcitonin - blood | Chemoembolization, Therapeutic | Kaplan-Meier Estimate | Proportional Hazards Models | Tumor Burden | Biomarkers, Tumor - blood | Carcinoma, Hepatocellular - pathology | Aged | Carcinoma, Hepatocellular - therapy | Chemotherapy | Usage | Care and treatment | Bacterial infections | Peptides | Diagnosis | Hepatoma | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: A meta-analysis
by Cai, Rong and Song, Rongfeng and Pang, Pengfei and Yan, Yan and Liao, Yifeng and Zhou, Cuiling and Wang, Shuncong and Zhou, Xiuling and Wang, Huaping and Zhang, Hongyu and Sun, Huanhuan and Ma, Haiqing
BMC Cancer, ISSN 1471-2407, 11/2017, Volume 17, Issue 1, pp. 714 - 9
Background: Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma... 
TACE | Advanced hepatocellular carcinoma | Clinical trial | Transcatheter arterial chemoembolization | Sorafenib | THERAPY | MANAGEMENT | ONCOLOGY | TRANSARTERIAL CHEMOEMBOLIZATION | HCC | RECURRENCE | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Humans | Middle Aged | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Niacinamide - administration & dosage | Chemoembolization, Therapeutic - methods | Phenylurea Compounds - administration & dosage | Survival Analysis | Aged, 80 and over | Female | Aged | Carcinoma, Hepatocellular - therapy | Care and treatment | Hepatoma | Comparative analysis | Patient outcomes | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization
by Gu, Jingxian and Zhang, Xing and Cui, Ruixia and Zhang, Jia and Wang, Zhixin and Jia, Yifan and Miao, Runchen and Dong, Yanyan and Ma, Xiaohua and Fan, Haining and Wang, Haijiu and Ren, Li and Li, Yiming and Niu, Wenquan and Zhang, Jingyao and Qu, Kai and Liu, Chang
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 07/2019, Volume 31, Issue 7, pp. 836 - 844
OBJECTIVESWe aimed to confirm the clinical effectiveness of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in patients with... 
ACTIVATED MONOCYTES | RISK-FACTORS | NEUTROPHIL | PERITUMORAL STROMA | prognostic predictor | CURATIVE RESECTION | ALANINE AMINOTRANSFERASE | PROMOTE EXPANSION | propensity score matching | TERM SURVIVAL | BLOOD MONOCYTE COUNT | TRANSARTERIAL CHEMOEMBOLIZATION | GASTROENTEROLOGY & HEPATOLOGY | hepatocellular carcinoma | postoperative adjuvant transcatheter arterial chemoembolization |